• 2年经验
  • 招若干人
  • 英语良好
  • 11-09 发布

职位描述

职位描述: KEY ACCOUNTIBILITIES:1. The candidates will have extensive theoretical knowledge as well as bench level experience in the identification and characterization of mAb using various techniques, such as library display (e.g. yeast, phage, etc), B- cell cloning and NGS method2. The candidate will be responsible for establishing and executing novel antibody discovery platform for generating antibody leads.3. The candidates will have good organizational and documentation skills and the ability to plan and simultaneously execute multiple antibody discovery projects.Industry experience is strong preferred but not absolutely required for the position.REQUIREMENTS:1.MS with > 5 years or PhD with > 2 years of relevant experience in therapeutic antibody lead generation through cell-based methods. Expertise in one of the following areas:2.B cell repertoire analysis using Next Generation Sequencing and molecular biology for antibody discovery.3.Hand on experience on cell culture and B cell cloning techniques for antibody discovery.4.Experience in the development of novel antibody discovery platforms.5.FACS sorting , single cell RT-PCR or B cell culture.6.A strong motivation in pursue science in drug discovery.Adaptable and productive in a fast-paced environmentGood communication skills required, including writing notebooks and presentation in English.Strong team-working spirit and excellent communication and inter-personal skills.EDUCATION (Indicate the mini. requirement & preferred discipline):Doctor degree in related Life Science subjects with >2-3 years related experience, or Master degree with > 5 years of industrialOTHER SKILLS, ABILITIES & EXPERIENCE:1.preferred but not required:2.Knowledge in immunology,especially B cell immunologyApplied knowledge of library construction and library display.Experience in antibody affinity maturation or humanization.Proficiency in applications of deep sequencing technologies 职能类别: 生物工程/生物制药 关键字: 生物新药发现 重组蛋白 纯化

联系方式

上海市外高桥保税区富特中路288号

公司信息

药明生物(WuXi Biologics)是香港上市公司(代码:2269),我们是全球领先的开放式、一体化生物制药能力和技术平台,旗下包括无锡药明康德生物技术股份有限公司、上海药明生物技术有限公司、苏州药明康德检测检验有限责任公司,并在美国和英国设有子公司。公司为全球生物制药公司和生物技术公司提供全方位的端到端研发服务,帮助任何人、任何公司发现、开发及生产生物药,实现从概念到商业化生产的全过程,加速全球生物药研发进程,降低研发成本,造福病患。目前,公司规模达到2300多人,有200多位拥有海外高等学位和工作经验的海归科学家,拥有丰富的欧美市场抗体开发、生产、质量控制、临床前研究和注册的经验,打造了世界一流的生物药研究、开发及生产团队。 更多信息,请登录公司官网:http://www.wuxibiologics.com.cn/

猎才二维码